Who Supplies Clindamycin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Clindamycin exports, with 527+ registered manufacturers shipping to buyers across 144+ countries — yet a handful of companies dominate the shipments. ENCUBE ETHICALS PRIVATE LIMITED holds the largest share at 14.3% (export value: $12.9M). Close behind, AUROBINDO PHARMA LTD (6.7%, $6.1M). AUROBINDO PHARMA LIMITED (6.2%, $5.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Clindamycin? Top Manufacturers & Their Buyers
Flow of Clindamycin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Clindamycin Supplier Network — Key Market Intelligence
The Clindamycin export market from India is led by ENCUBE ETHICALS PRIVATE LIMITED, which alone commands a 14.3% share, shipping $12.9M worth of product across 291 shipments. The second-largest exporter, AUROBINDO PHARMA LTD, contributes $6.1M (6.7%) to the overall market. Combined, the top two suppliers alone account for 21.1% of all Clindamycin exports, indicating a relatively concentrated supply base.
Across all 527 tracked manufacturers, the total Clindamycin export value stands at $90.2M from 7.2K shipments. The market average shipment value is $12.5K. The single largest buyer relationship in terms of trade value is CARDINAL HEALTH, receiving $4.7M worth of product.
The combined buyer network spans 17 named purchasing companies, including CARDINAL HEALTH, IPD, SC, USA, AIM RX 3PL, LLC, MCKESSON THIRD PARTY, AUROLOGISTICS LLC (AUROBINDO PHARMA and 12 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1ENCUBE ETHICALS PRIVATE LIMITED
ENCUBE ETHICALS PRIVATE LIMITED is the first-largest Clindamycin exporter from India, with a market share of 14.3% and a total export value of $12.9M across 291 shipments. Their average shipment value of $44.4K is above the market average of $12.5K, suggesting premium or bulk contract pricing.
ENCUBE ETHICALS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• CARDINAL HEALTH — $4.7M across 107 shipments (36.7% of this supplier's total exports)
• IPD, SC, USA — $4.6M across 104 shipments (35.8% of this supplier's total exports)
• AIM RX 3PL, LLC — $1.6M across 37 shipments (12.7% of this supplier's total exports)
• IPD, SC, USA — $1.1M across 24 shipments (8.2% of this supplier's total exports)
• MCKESSON THIRD PARTY — $854.6K across 19 shipments (6.6% of this supplier's total exports)
Key Insight: ENCUBE ETHICALS PRIVATE LIMITED's per-shipment value of $44.4K is 257% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.
2AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the second-largest Clindamycin exporter from India, with a market share of 6.7% and a total export value of $6.1M across 188 shipments. Their average shipment value of $32.3K is above the market average of $12.5K, suggesting premium or bulk contract pricing.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. AUROLOGISTICS LLC (AUROBINDO PHARMA is the dominant customer, accounting for 65.4% of this supplier's tracked business. Top customers include:
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $4.0M across 123 shipments (65.4% of this supplier's total exports)
• AUROLOGISTICS LLC — $842.0K across 26 shipments (13.8% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $488.7K across 15 shipments (8.0% of this supplier's total exports)
• AURO PHARMA INC — $408.2K across 13 shipments (6.7% of this supplier's total exports)
• AUROLOGISTICS LLC — $366.6K across 11 shipments (6.0% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD's per-shipment value of $32.3K is 160% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.
3AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED is the third-largest Clindamycin exporter from India, with a market share of 6.2% and a total export value of $5.6M across 63 shipments. Their average shipment value of $89.2K is above the market average of $12.5K, suggesting premium or bulk contract pricing.
AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. AUROLOGISTICS LLC AUROBINDO PHARM is the dominant customer, accounting for 67.4% of this supplier's tracked business. Top customers include:
• AUROLOGISTICS LLC AUROBINDO PHARM — $3.8M across 42 shipments (67.4% of this supplier's total exports)
• AUROLOGISTICS LLC — $701.3K across 8 shipments (12.5% of this supplier's total exports)
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $423.5K across 5 shipments (7.5% of this supplier's total exports)
• AUROBINDO PHARMA USA — $383.8K across 4 shipments (6.8% of this supplier's total exports)
• AURO PHARMA INC — $326.7K across 4 shipments (5.8% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LIMITED's per-shipment value of $89.2K is 616% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.
4MICRO LABS LIMITED
MICRO LABS LIMITED is the fourth-largest Clindamycin exporter from India, with a market share of 4.8% and a total export value of $4.3M across 93 shipments. Their average shipment value of $46.3K is above the market average of $12.5K, suggesting premium or bulk contract pricing.
MICRO LABS LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES LLC is the dominant customer, accounting for 56.1% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES LLC — $2.4M across 52 shipments (56.1% of this supplier's total exports)
• EVERSANA LIFE SCIENCE SERVICES LLC — $1.6M across 34 shipments (36.1% of this supplier's total exports)
• EVERSANA LIFE SCIENCE SERVICES LLC — $230.3K across 5 shipments (5.3% of this supplier's total exports)
• MICRO HEALTHCARE (PR — $55.7K across 1 shipments (1.3% of this supplier's total exports)
• BROWN AND BURK UK LI — $47.4K across 1 shipments (1.1% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED's per-shipment value of $46.3K is 272% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.
5BIOMATRIX HEALTHCARE PRIVATE LIMITED
BIOMATRIX HEALTHCARE PRIVATE LIMITED is the fifth-largest Clindamycin exporter from India, with a market share of 3.7% and a total export value of $3.4M across 62 shipments. Their average shipment value of $54.1K is above the market average of $12.5K, suggesting premium or bulk contract pricing.
BIOMATRIX HEALTHCARE PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• UNIQUE PHARMA, — $1.6M across 30 shipments (48.1% of this supplier's total exports)
• UNICA FARMA, LDA. — $1.5M across 28 shipments (44.8% of this supplier's total exports)
• UNIQUE PHARMA, — $180.5K across 3 shipments (5.4% of this supplier's total exports)
• UNICA FARMA, LDA. — $33.4K across 1 shipments (1.0% of this supplier's total exports)
• ACE HEALTH CARE LDA — $23.7K across 0 shipments (0.7% of this supplier's total exports)
Key Insight: BIOMATRIX HEALTHCARE PRIVATE LIMITED's per-shipment value of $54.1K is 334% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.
6GLENMARK PHARMACEUTICALS LIMITED
GLENMARK PHARMACEUTICALS LIMITED is the fifth-largest Clindamycin exporter from India, with a market share of 3.1% and a total export value of $2.8M across 199 shipments. Their average shipment value of $13.9K is above the market average of $12.5K, suggesting premium or bulk contract pricing.
GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NORTHSTAR DISTRIBUTION CENTER 8912 — $870.6K across 63 shipments (31.5% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC., USA — $721.7K across 52 shipments (26.1% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $571.3K across 41 shipments (20.7% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC., USA — $318.8K across 23 shipments (11.5% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC., USA — $281.9K across 20 shipments (10.2% of this supplier's total exports)
Key Insight: GLENMARK PHARMACEUTICALS LIMITED's per-shipment value of $13.9K is 11% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Clindamycin Flows
Once Clindamycin leaves the manufacturing plants of companies like ENCUBE ETHICALS PRIVATE LIMITED and AUROBINDO PHARMA LTD, it travels to 5 destination markets with a combined import value of $90.2M. United States absorbs the largest share at 60.9% ($55.0M), followed by Kenya (5.1%) and Philippines (4.0%).
In United States — the top destination — named importers include CARDINAL HEALTH, EVERSANA LIFE SCIENCE SERVICES, LLC, IPD, SC, USA. In Kenya, key buyers are SYNERMED PHARMACEUTICALS (KENYA)LTD, WESSEX PHARMACEUTICALS LIMITED,.
This geographic spread reflects Clindamycin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Clindamycin Go? Top Importing Countries & Their Buyers
Trade flow of Clindamycin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Clindamycin imports from India, with a total trade value of $55.0M across 688 shipments — representing a 60.9% share of all Clindamycin exports. The average shipment value of $79.9K is above the global average of $12.5K, indicating high-value procurement contracts or branded formulations. This market is served by 13 tracked buyers.
Named Clindamycin importers in United States: CARDINAL HEALTH is the largest buyer, accounting for 10.5% ($5.8M) of this market's total imports.
• CARDINAL HEALTH — $5.8M (10.5% of United States's total)
• EVERSANA LIFE SCIENCE SERVICES, LLC — $4.8M (8.7% of United States's total)
• IPD, SC, USA — $4.8M (8.7% of United States's total)
Key Insight: United States's per-shipment average of $79.9K (541% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Clindamycin imports from India.
2Kenya
Kenya ranks as the second-largest destination for Clindamycin imports from India, with a total trade value of $4.6M across 19 shipments — representing a 5.1% share of all Clindamycin exports. The average shipment value of $240.5K is above the global average of $12.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Clindamycin importers in Kenya: SYNERMED PHARMACEUTICALS (KENYA)LTD is the largest buyer, accounting for 58.1% ($2.7M) of this market's total imports.
• SYNERMED PHARMACEUTICALS (KENYA)LTD — $2.7M (58.1% of Kenya's total)
• WESSEX PHARMACEUTICALS LIMITED, — $1.2M (27.3% of Kenya's total)
Key Insight: Kenya's per-shipment average of $240.5K (1830% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Kenya is a key market for Clindamycin imports from India.
3Philippines
Philippines ranks as the third-largest destination for Clindamycin imports from India, with a total trade value of $3.7M across 4 shipments — representing a 4.0% share of all Clindamycin exports. The average shipment value of $912.8K is above the global average of $12.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Clindamycin importers in Philippines: NELPA LIFESCIENCES INC is the largest buyer, accounting for 58.0% ($2.1M) of this market's total imports.
• NELPA LIFESCIENCES INC — $2.1M (58.0% of Philippines's total)
Key Insight: Philippines's per-shipment average of $912.8K (7225% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Clindamycin imports from India.
4Myanmar
Myanmar ranks as the fourth-largest destination for Clindamycin imports from India, with a total trade value of $3.1M across 3 shipments — representing a 3.4% share of all Clindamycin exports. The average shipment value of $1.0M is above the global average of $12.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Clindamycin importers in Myanmar: LEGEND CREATIVES CO. LTD. is the largest buyer, accounting for 97.2% ($3.0M) of this market's total imports.
• LEGEND CREATIVES CO. LTD. — $3.0M (97.2% of Myanmar's total)
Key Insight: Myanmar's per-shipment average of $1.0M (8174% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Myanmar is a key market for Clindamycin imports from India.
5Canada
Canada ranks as the fifth-largest destination for Clindamycin imports from India, with a total trade value of $2.1M across 0 shipments — representing a 2.3% share of all Clindamycin exports. The average shipment value of $2.1M is above the global average of $12.5K, indicating high-value procurement contracts or branded formulations.
Key Insight: Canada's per-shipment average of $2.1M (16902% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Clindamycin imports from India.
People Also Ask — Clindamycin Supplier & Trade Network
Who are the top suppliers of Clindamycin from India?+
Which companies buy Clindamycin from Indian manufacturers?+
Where does Clindamycin exported from India go?+
What is the market share of the top Clindamycin supplier from India?+
What is the average shipment value for Clindamycin exports from India?+
Is Clindamycin manufactured in India and exported globally?+
Which country imports the most Clindamycin from India?+
Who are the buyers of Clindamycin in Kenya?+
How concentrated is the Clindamycin supplier market in India?+
How do I find verified buyers for Clindamycin in specific countries?+
Clindamycin Trade Network — Key Takeaways
- 1ENCUBE ETHICALS PRIVATE LIMITED is India's dominant Clindamycin exporter with a 14.3% market share and $12.9M in total exports — making it the single most important sourcing entity in this market.
- 2The top 527 suppliers collectively account for 38.8% of all tracked Clindamycin exports, with a combined trade value of $90.2M.
- 3United States is the largest destination market, absorbing 60.9% of India's Clindamycin exports ($55.0M). Kenya (5.1%) and Philippines (4.0%) follow.
- 4With 7.2K total shipments averaging $12.5K each, the Clindamycin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include CARDINAL HEALTH, IPD, SC, USA, AUROLOGISTICS LLC (AUROBINDO PHARMA, AUROLOGISTICS LLC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 144 countries
Network value: $90.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clindamycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Clindamycin.
- 2.Flow Mapping: 527 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 7,242 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 144 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7,242 Verified Shipments
527 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists